The Project Orca is developed in a brownfield site in Visp, Switzerland. This site provides additional manufacturing capacity for the Lonza GMP Manufacturing facility in the Ibex Biopark. The facility is to be focused on products derived from mammalian cell culture for bulk drug products and is flexible to accommodate multiple clients and products.
The facility is built in one wing of the new MC2 building with the intent to future production modules within this building. Utilities and logistics are adaptable for future production.